Since the inflammatory chemokines are regarded as key mediators for inflammatory immune cell recruitment and induction of chronic sub-acute inflammation, we further asked if the changes in fractalkine expression were related with systemic inflammatory chemokines in T2D and/or non-diabetic subjects. The gene discussed is CX3CL1; the disease is type 2 diabetes mellitus.